Table 1 IC50 (mM) of cells after 1, 16 and 72-h treatments with ascorbate
Cancer lines | Patient-derived Non-SRCC | Patient-derived SRCC | SRCC cell lines | Pancreatic | Ovarian | ||
|---|---|---|---|---|---|---|---|
Treatment (hr) | Time of assessment (hr) | GPM-1 | GPM-2 | HSC-39 | KATO-3 | MIA PaCA-2 | SKOV-3 |
1 | 72 | 10.3 ± 4.15 | 13.1 ± 5.48 | 10.2 ± 2.09 | 22.9 ± 5.57 | 9.67 ± 4.90 | 54.6 ± 39.2 |
16 | 72 | 6.75 ± 3.92 | 4.79 ± 0.96 | 3.34 ± 0.97 | 3.78 ± 1.80 | 3.76 ± 1.78 | 7.67 ± 1.93 |
72 | 72 | 5.88 ± 2.80 | 3.70 ± 0.79 | 2.06 ± 0.44 | 2.55 ± 1.83 | 2.76 ± 1.42 | 5.85 ± 3.75 |